Gadofosveset-enhanced magnetic resonance angiography

Gadofosveset (Vasovist(®), Bayer Schering Pharma AG, Berlin/Germany) is the first intravascular contrast agent approved for use with magnetic resonance angiography in the European Union, Switzerland, Turkey, Canada, and Australia. Gadofosveset reversibly binds to albumin providing extended intravasc...

Descripción completa

Detalles Bibliográficos
Autor principal: Goyen, Mathias
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2008
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2464762/
https://www.ncbi.nlm.nih.gov/pubmed/18629367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2464762/
https://www.ncbi.nlm.nih.gov/pubmed/18629367

Ejemplares similares